Products for Research Use Only
RegisterLogin

Fosfomycin (sodium)

CAT: 0804-HY-W016420-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W016420-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fosfomycin (MK-0955) sodium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin sodium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria[1][2].
CAS Number
26016-99-9
Product Name Alternative
MK-0955 (sodium)
UNSPSC
12352005
Hazard Statement
H302
Target
Antibiotic; Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/fosfomycin-sodium.html
Purity
98.0
Solubility
H2O : 125 mg/mL (ultrasonic)
Smiles
C[C@@H]1O[C@@H]1P(O[Na])(O[Na])=O
Molecular Formula
C3H5Na2O4P
Molecular Weight
182.02
Precautions
H302
References & Citations
[1]Falagas ME, et al. Fosfomycin. Clin Microbiol Rev. 2016 Apr. 29 (2) :321-47.|[2]Dijkmans AC, et al. Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics (Basel) . 2017 Oct 31. 6 (4) :24. |[3]Inouye S, et al. Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin. J Pharmacobiodyn. 1982 Sep. 5 (9) :659-69.|[4]Inouye S, et al. Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats. J Pharmacobiodyn. 1982 Dec. 5 (12) :941-50.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Launched
Citation 01
ACS Infect Dis. 2024 Aug 9;10 (8) :2961-2977.|Antibiotics (Basel) . 2021 Sep 14;10 (9) :1110.|bioRxiv. 2024 May 10.|bioRxiv. 2025 January 19.|J Antibiot (Tokyo) . 2025 Mar;78 (4) :265-273.|MedComm (2020) . 2025 Jan 8;6 (1) :e70046.|Molecules. 2025 Mar 9;30 (6) :1224.|Nat Commun. 2022 Mar 2;13 (1) :1116.|Front Cell Infect Microbiol. 2019 Jul 15:9:253.|J Med Microbiol. 2019 Mar;68 (3) :493-502.|Infect Genet Evol. 2025 Sep:133:105780.|Microb Pathog. 2025 Oct 25.|Microbiol Spectr. 2025 Sep 2;13 (9) :e0152125.

Related Products

CatalogName
HY-B1075AFosfomycin
HY-B1075Fosfomycin (calcium)
HY-B0609-01Fosfomycin (tromethamine)
HY-B1075R-01Fosfomycin (calcium) (Standard)
HY-W748107(Rac) -Fosfomycin-d5 (benzylamine)
HY-B1075AS-01(Rac) -Fosfomycin (benzylamine) -13C3
HY-N15194AInostamycin A (sodium)
HY-166084Docosatetraenoate (sodium)
HY-16366ABriciclib (sodium)
HY-150364AFarabursen (sodium)

Alternative Products

CatalogName
F013-5GFosfomycin Sodium
587076-01Fosfomycin-beta-D-galactopyranoside Sodium
AR-F10900-01Fosfomycin Impurity 14 (Sodium salt)
C39SD1091Fosfomycin
RM-F061324-01Fosfomycin Impurity 24 (Fosfomycin Diastereomer)
C6467-50Fosfomycin Tromethamine
C6497-25Fosfomycin Disodium
FF34050-01Fosfomycin phenylethylamine
AF126315-01Fosfomycin calcium

Popular Products